PR

DR. NOAH BIOTECH CEO JI-HYUN LEE gave a presentation titled Designing Drug Combinations for Orphan Diseases at ‘THE AI KOREA 2020 Conference’ held online on 27th.

In its introductory remark, Ms. Lee said, "Our effort to incorporate AI technology into pharmaceutical development to increase efficiency and shorten the development period has continued up to now. In the global market, biotech companies, equipped with AI technology, are rubbing shoulders with multinational pharmaceuticals to develop new drugs with great success by attracting investment worth tens of and hundreds of billions of won. The country already saw more than ten AI companies jumping into the competition to bring a new drug into the global market. Under the circumstances, I would like to introduce DR. NOAH BIOTECH's strategy to develop its own AI-applied treatment for rare disease."

The event held by AI Scoeity of the Korean Institute of Information Scientists and Engineers was held online from Aug. 27 to 28th, in which CEO Lee finished her presentation at AI Business session on Aug. 27th.